FDA to authorize two batches of Johnson & Johnson COVID vaccine made at troubled Baltimore plant; others likely to be tossed

Federal regulators at the U.S. Food and Drug Administration will authorize for use two batches of Johnson & Johnson’s COVID-19 vaccine manufactured at the troubled Baltimore facility where critical production errors rendered millions of doses unusable earlier this year.